(S)-3-(3-methoxy-4-(4-(1,4,5,6-tetrahydropyrimidin-2-ylamino)piperidin-1-yl)benzamido)-2-(phenylsulfonamido)propanoic acid

ID: ALA1083695

Cas Number: 247034-73-7

PubChem CID: 10281105

Max Phase: Preclinical

Molecular Formula: C26H34N6O6S

Molecular Weight: 558.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)NC[C@H](NS(=O)(=O)c2ccccc2)C(=O)O)ccc1N1CCC(NC2=NCCCN2)CC1

Standard InChI:  InChI=1S/C26H34N6O6S/c1-38-23-16-18(8-9-22(23)32-14-10-19(11-15-32)30-26-27-12-5-13-28-26)24(33)29-17-21(25(34)35)31-39(36,37)20-6-3-2-4-7-20/h2-4,6-9,16,19,21,31H,5,10-15,17H2,1H3,(H,29,33)(H,34,35)(H2,27,28,30)/t21-/m0/s1

Standard InChI Key:  YYKYFRLZWKUEIZ-NRFANRHFSA-N

Molfile:  

     RDKit          2D

 39 42  0  0  0  0  0  0  0  0999 V2000
    7.2375  -21.3731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2375  -22.2027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520  -22.6152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6711  -22.2027    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6711  -21.3731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9520  -20.9560    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3860  -20.9613    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.1000  -21.3746    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0947  -22.1991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8047  -22.6122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5221  -22.2040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.5249  -21.3780    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8103  -20.9603    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2321  -22.6198    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2269  -23.4460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9386  -23.8618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6561  -23.4527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6574  -22.6234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9451  -22.2112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9467  -21.3861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.6621  -20.9751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3691  -23.8676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3663  -24.6927    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0850  -23.4576    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7981  -23.8726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5140  -23.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2270  -23.8775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9430  -23.4674    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.2242  -24.7026    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.5169  -22.6375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2328  -22.2274    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.2356  -21.4024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9400  -21.8085    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6375  -22.9361    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.9532  -20.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.9564  -20.1720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2428  -19.7562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5244  -20.1707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.5248  -20.9935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 19 14  1  0
 11 14  1  0
  2  3  1  0
 19 20  1  0
  3  4  1  0
 20 21  1  0
  4  5  2  0
 17 22  1  0
  5  6  1  0
 22 23  2  0
  8 13  1  0
 22 24  1  0
  9 10  1  0
 24 25  1  0
 10 11  1  0
 25 26  1  0
 11 12  1  0
 26 27  1  0
 12 13  1  0
 27 28  1  0
 27 29  2  0
  5  7  1  0
 26 30  1  6
 14 15  2  0
 30 31  1  0
  1  2  1  0
 31 32  1  0
 15 16  1  0
 31 33  2  0
  7  8  1  0
 31 34  2  0
 16 17  2  0
 32 35  2  0
  8  9  1  0
 35 36  1  0
 17 18  1  0
 36 37  2  0
  1  6  1  0
 37 38  1  0
 18 19  2  0
 38 39  2  0
 39 32  1  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VTN Tbio Vitronectin (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 558.66Molecular Weight (Monoisotopic): 558.2261AlogP: 0.76#Rotatable Bonds: 10
Polar Surface Area: 161.46Molecular Species: ZWITTERIONHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.87CX Basic pKa: 11.78CX LogP: -1.06CX LogD: -1.06
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.28Np Likeness Score: -0.99

References

1. Allen JG, Fotsch C, Babij P..  (2010)  Emerging targets in osteoporosis disease modification.,  53  (11): [PMID:20218623] [10.1021/jm9018756]
2. Ishikawa M, Hashimoto Y..  (2011)  Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry.,  54  (6): [PMID:21344906] [10.1021/jm101356p]

Source